Franzese Ciro, Lopci Egesta, Di Brina Lucia, D'Agostino Giuseppe Roberto, Navarria Pierina, Mancosu Pietro, Tomatis Stefano, Chiti Arturo, Scorsetti Marta
a Radiotherapy and Radiosurgery , Humanitas Clinical and Research Center , Via Manzoni Rozzano ( Milano ) - Italy.
b Nuclear Medicine , Humanitas Clinical and Research Center , Via Manzoni Rozzano ( Milano ) - Italy.
Cancer Invest. 2017 Oct 21;35(9):586-593. doi: 10.1080/07357907.2017.1375116. Epub 2017 Oct 5.
aim is outcome of 11C-Choline-PET guided SBRT on lymph node metastases.
patients with 1 - 4 lymph node metastases detected by 11C-choline-PET were treated with SBRT. Toxicity, treated metastases control and Progression Free Survival were computed.
twenty-six patients, 38 lymph node metastases were irradiated. No grade ≥ 2 toxicity. Median PSA-nadir after RT was 1.02 ng/mL. Post-treatment 11C-Choline-PET showed metabolic complete response in 17 metastases (44,7%), partial response in 9 metastases (38%).
SBRT is effective and safe for lymph node metastases. PET is important in identification of gross tumor and evaluation of the response.
目的是探讨11C-胆碱正电子发射断层扫描(PET)引导下的立体定向体部放疗(SBRT)对淋巴结转移灶的治疗效果。
对11C-胆碱PET检测出1 - 4个淋巴结转移灶的患者进行SBRT治疗。计算毒性反应、治疗后转移灶控制情况及无进展生存期。
26例患者,共38个淋巴结转移灶接受了放疗。无≥2级毒性反应。放疗后前列腺特异抗原(PSA)最低值中位数为1.02 ng/mL。治疗后11C-胆碱PET显示17个转移灶(44.7%)代谢完全缓解,9个转移灶(38%)部分缓解。
SBRT对淋巴结转移灶有效且安全。PET在大体肿瘤识别及疗效评估中具有重要作用。